Mizoribine versus mycophenolate mofetil or intravenous cyclophosphamide for induction treatment of active lupus nephritis

Xuebing Feng, Fei Gu, Weiwei Chen, Yan Liu, Wei Hua, Lin Liu, Songlou Yin, Zhanyun Da, Lingyun SunChinese 2014 · DOI

Abstract

MZR is well tolerated and has an effect similar to MMF in the induction therapy of active LN. MZR may serve as an alternative approach for LN patients.
BibTeX
@inproceedings{feng2014mizoribine,
  author = {Xuebing Feng and Fei Gu and Weiwei Chen and Yan Liu and Wei Hua and Lin Liu and Songlou Yin and Zhanyun Da and Lingyun Sun},
  title = {{Mizoribine versus mycophenolate mofetil or intravenous cyclophosphamide for induction treatment of active lupus nephritis}},
  booktitle = {Chinese},
  year = {2014},
  doi = {10.3760/cma.j.issn.0366-6999.20140627},
}

Loading related content...

Figure